LD

Lahu Dadabhau Somavanshi

Active Director Partner DIN 06484362
DIN 06484362 First appointment Sep 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Lahu Dadabhau Somavanshi

Data last updated:

Lahu Dadabhau Somavanshi is a Partner at Tieten Medicity Hospital Llp (since 2026).

DIN 06484362
Primary Designation Partner
First Appointment 03 Sep 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Partner03 Sep 20262026Active

Board colleagues of Lahu Dadabhau Somavanshi

Directorship timeline

Open interactive timeline →
Tieten Medicity Hospital Llp
Premium access

Shareholding and investment profile for Lahu Dadabhau Somavanshi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Lahu Dadabhau Somavanshi

Lahu Dadabhau Somavanshi currently holds 1 directorship: Tieten Medicity Hospital Llp (Partner, since 03 Sep 2026).

Lahu Dadabhau Somavanshi was first appointed on 03 Sep 2026 as Partner at Tieten Medicity Hospital Llp.

The current boards of Lahu Dadabhau Somavanshi's companies include Abrar Haroon Khan (Tieten Medicity Hospital Llp), Jugalkishor Brahmdev Pandey (Tieten Medicity Hospital Llp), Mayuri Vijaykumar Shetty (Tieten Medicity Hospital Llp), Neena Sunil Nichalani (Tieten Medicity Hospital Llp), Pradeep Rampratap Tripathi (Tieten Medicity Hospital Llp), Rimzim Nandlal Jialdasani (Tieten Medicity Hospital Llp), among others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available